Published in Medicine and Law Weekly, January 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Stem Cell Therapeutics.
Report 1: Stem Cell Therapeutics Corp. (SCT) announced the formation of its clinical advisory board (CAB) with three well-known clinicians, Steven Cramer, MD, Hannelore Ehrenreich, MD, and Michael Hill, MD, who have agreed to provide input and guidance on SCT's current stroke program with NTx-265.
The board also will address potential future programs in schizophrenia, multiple sclerosis, traumatic brain injury, and Huntington disease.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.